Germline copy number variations are associated with breast cancer risk and prognosis

Breast cancer is one of the most common cancers among women, and susceptibility is explained by genetic, lifestyle and environmental components. Copy Number Variants (CNVs) are structural DNA variations that contribute to diverse phenotypes via gene-dosage effects or cis-regulation. In this study, we aimed to identify germline CNVs associated with breast cancer susceptibility and their relevance to prognosis. We performed whole genome CNV genotyping in 422 cases and 348 controls using Human Affymetrix SNP 6 array. Principal component analysis for population stratification revealed 84 outliers leaving 366 cases and 320 controls of Caucasian ancestry for association analysis; CNVs with frequency > 10% and overlapping with protein coding genes were considered for breast cancer risk and prognostic relevance. Coding genes within the CNVs identified were interrogated for gene- dosage effects by correlating copy number status with gene expression profiles in breast tumor tissue. We identified 200 CNVs associated with breast cancer (q-value < 0.05). Of these, 21 CNV regions (overlapping with 22 genes) also showed association with prognosis. We validated representative CNVs overlapping with APOBEC3B and GSTM1 genes using the TaqMan assay. Germline CNVs conferred dosage effects on gene expression in breast tissue. The candidate CNVs identified in this study warrant independent replication.

[1]  Tomas W. Fitzgerald,et al.  Origins and functional impact of copy number variation in the human genome , 2010, Nature.

[2]  P. Grambsch,et al.  Modeling Survival Data: Extending the Cox Model , 2000 .

[3]  G. Capellá,et al.  Candidate predisposing germline copy number variants in early onset colorectal cancer patients , 2017, Clinical and Translational Oncology.

[4]  D. Carraro,et al.  ROBO1 deletion as a novel germline alteration in breast and colorectal cancer patients , 2016, Tumor Biology.

[5]  S. Seal,et al.  PALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility gene , 2007, Nature Genetics.

[6]  S. Damaraju,et al.  A Genome-Wide Association Study to Identify Potential Germline Copy Number Variants for Sporadic Breast Cancer Susceptibility , 2016, Cytogenetic and Genome Research.

[7]  R. Ankathil,et al.  Influence of germline polymorphisms of GSTT1, GSTM1, and GSTP1 in familial versus sporadic breast cancer susceptibility and survival , 2007, Familial Cancer.

[8]  Yifeng Zhou,et al.  A functional copy-number variation in MAPKAPK2 predicts risk and prognosis of lung cancer. , 2012, American journal of human genetics.

[9]  Jake K. Byrnes,et al.  Genome-wide association study of copy number variation in 16,000 cases of eight common diseases and 3,000 shared controls , 2010 .

[10]  Yan Guo,et al.  Genome-wide copy-number-variation study identified a susceptibility gene, UGT2B17, for osteoporosis. , 2008, American journal of human genetics.

[11]  R Core Team,et al.  R: A language and environment for statistical computing. , 2014 .

[12]  S. Bojesen,et al.  Copy number variation in glutathione-S-transferase T1 and M1 predicts incidence and 5-year survival from prostate and bladder cancer, and incidence of corpus uteri cancer in the general population , 2011, The Pharmacogenomics Journal.

[13]  R. Kuiper,et al.  Germline copy number variation and cancer risk. , 2010, Current opinion in genetics & development.

[14]  A. Kallioniemi,et al.  Rare Copy Number Variants Observed in Hereditary Breast Cancer Cases Disrupt Genes in Estrogen Signaling and TP53 Tumor Suppression Network , 2012, PLoS genetics.

[15]  Kenny Q. Ye,et al.  Large-Scale Copy Number Polymorphism in the Human Genome , 2004, Science.

[16]  M. Beckmann,et al.  Association between a germline OCA2 polymorphism at chromosome 15q13.1 and estrogen receptor-negative breast cancer survival. , 2010, Journal of the National Cancer Institute.

[17]  John T. Wei,et al.  Identification of functionally active, low frequency copy number variants at 15q21.3 and 12q21.31 associated with prostate cancer risk , 2012, Proceedings of the National Academy of Sciences.

[18]  C. Mathers,et al.  Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012 , 2015, International journal of cancer.

[19]  A. Dreher.  Modeling Survival Data Extending The Cox Model , 2016 .

[20]  Chen,et al.  Genome-wide analysis associates familial colorectal cancer with increases in copy number variations and a rare structural variation at 12 p 12 . 3 , 2014 .

[21]  C. Maugard,et al.  Allelotype influence at glutathione S-transferase M1 locus on breast cancer susceptibility , 1999, British Journal of Cancer.

[22]  Charles Lee,et al.  The clinical context of copy number variation in the human genome , 2010, Expert Reviews in Molecular Medicine.

[23]  P. Grambsch,et al.  A Package for Survival Analysis in S , 1994 .

[24]  J. Yokota,et al.  Contribution of germline mutations to PARK2 gene inactivation in lung adenocarcinoma , 2012, Genes, chromosomes & cancer.

[25]  Jaana M. Hartikainen,et al.  Large-scale genotyping identifies 41 new loci associated with breast cancer risk , 2013, Nature Genetics.

[26]  Jonathan W. Pillow,et al.  POSTER PRESENTATION Open Access , 2013 .

[27]  L. Kiemeney,et al.  Germline deletions in the tumour suppressor gene FOCAD are associated with polyposis and colorectal cancer development , 2015, The Journal of pathology.

[28]  Marilyn M. Li,et al.  Characterization of germline copy number variation in high‐risk African American families with prostate cancer , 2013, The Prostate.

[29]  F. Couch,et al.  A Genome Wide Meta-Analysis Study for Identification of Common Variation Associated with Breast Cancer Prognosis , 2014, PloS one.

[30]  R. Vierkant,et al.  Germline Copy Number Variation and Ovarian Cancer Survival , 2012, Front. Gene..

[31]  E. Gamazon,et al.  Genetic factors affecting gene transcription and catalytic activity of UDP-glucuronosyltransferases in human liver. , 2014, Human molecular genetics.

[32]  Lester L. Peters,et al.  Genome-wide association study identifies novel breast cancer susceptibility loci , 2007, Nature.

[33]  W. Krzyzosiak,et al.  Copy number variation of microRNA genes in the human genome , 2011, BMC Genomics.

[34]  T. Ørntoft,et al.  Frequent genomic loss at chr16p13.2 is associated with poor prognosis in colorectal cancer , 2011, International journal of cancer.

[35]  R. Scott,et al.  Copy Number Variation in Hereditary Non-Polyposis Colorectal Cancer , 2013, Genes.

[36]  The Polish Breast Cancer Consortium.  Low-penetrance susceptibility to breast cancer due to CHEK2*1100delC in noncarriers of BRCA1 or BRCA2 mutations , 2002 .

[37]  Jake K. Byrnes,et al.  Genome-wide association study of copy number variation in 16,000 cases of eight common diseases and 3,000 shared controls , 2010, Nature.

[38]  L. Feuk,et al.  Detection of large-scale variation in the human genome , 2004, Nature Genetics.

[39]  L. Fan,et al.  A functional polymorphism in the promoter region of GSTM1 implies a complex role for GSTM1 in breast cancer , 2009, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[40]  Julian Peto,et al.  Identification of the breast cancer susceptibility gene BRCA2 , 1996, Nature.

[41]  Jianxin Shi,et al.  Rare Germline Copy Number Variations and Disease Susceptibility in Familial Melanoma. , 2016, The Journal of investigative dermatology.

[42]  J. Carpten,et al.  Genome-wide copy-number variation analysis identifies common genetic variants at 20p13 associated with aggressiveness of prostate cancer. , 2011, Carcinogenesis.

[43]  R. Scott,et al.  Expanding the genetic basis of copy number variation in familial breast cancer , 2014, Hereditary cancer in clinical practice.

[44]  P. Robson,et al.  Identification of a Breast Cancer Susceptibility Locus at 4q31.22 Using a Genome-Wide Association Study Paradigm , 2013, PloS one.

[45]  R. Bontrop,et al.  Insights on the functional interactions between miRNAs and copy number variations in the aging brain , 2013, Front. Mol. Neurosci..

[46]  Steven E. Bayer,et al.  A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. , 1994, Science.

[47]  J. R. MacDonald,et al.  A copy number variation map of the human genome , 2015, Nature Reviews Genetics.

[48]  Massimo Midiri,et al.  Analysis of Germline Gene Copy Number Variants of Patients with Sporadic Pancreatic Adenocarcinoma Reveals Specific Variations , 2013, Oncology.

[49]  Michael Krawczak,et al.  Genome-wide analysis associates familial colorectal cancer with increases in copy number variations and a rare structural variation at 12p12.3. , 2014, Carcinogenesis.

[50]  Albino Martins,et al.  Overexpression of platelet-derived growth factor receptor α in breast cancer is associated with tumour progression , 2005, Breast Cancer Research.

[51]  J. Schleutker,et al.  Germline copy number variation analysis in Finnish families with hereditary prostate cancer , 2016, The Prostate.

[52]  L. Strong,et al.  Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. , 1990, Science.

[53]  Brent S. Pedersen,et al.  Copy neutral loss of heterozygosity is more frequent in older ovarian cancer patients , 2013, Genes, chromosomes & cancer.

[54]  Nazneen Rahman,et al.  Low-penetrance susceptibility to breast cancer due to CHEK2*1100delC in noncarriers of BRCA1 or BRCA2 mutations , 2002, Nature Genetics.

[55]  J. González,et al.  Identification of Copy Number Variants Defining Genomic Differences among Major Human Groups , 2009, PloS one.

[56]  M. Taheri,et al.  APOBEC3 Deletion is Associated with Breast Cancer Risk in a Sample of Southeast Iranian Population , 2015, International journal of molecular and cellular medicine.

[57]  L. Fan,et al.  Genetic variants in GSTM3 gene within GSTM4-GSTM2-GSTM1-GSTM5-GSTM3 cluster influence breast cancer susceptibility depending on GSTM1 , 2010, Breast Cancer Research and Treatment.

[58]  Nazneen Rahman,et al.  ATM mutations that cause ataxia-telangiectasia are breast cancer susceptibility alleles , 2006, Nature Genetics.

[59]  J. Holloway,et al.  Copy-number variation genotyping of GSTT1 and GSTM1 gene deletions by real-time PCR. , 2009, Clinical chemistry.

[60]  Peter Kraft,et al.  A Genome-Wide Association Study of Prognosis in Breast Cancer , 2010, Cancer Epidemiology, Biomarkers & Prevention.

[61]  Bradley P. Coe,et al.  Germline DNA Copy Number Aberrations Identified as Potential Prognostic Factors for Breast Cancer Recurrence , 2013, PloS one.

[62]  Rare germline copy number deletions of likely functional importance are implicated in endometrial cancer predisposition , 2015, Human Genetics.

[63]  Gonçalo Abecasis,et al.  Deletion of the late cornified envelope LCE3B and LCE3C genes as a susceptibility factor for psoriasis , 2009, Nature Genetics.

[64]  John Wei,et al.  Towards a comprehensive structural variation map of an individual human genome , 2010, Genome Biology.

[65]  P. Pearson,et al.  Germline DNA copy number variation in familial and early-onset breast cancer , 2012, Breast Cancer Research.

[66]  G. Mills,et al.  The emerging role of lysophosphatidic acid in cancer , 2003, Nature Reviews Cancer.

[67]  Jing Hua Zhao,et al.  gap: Genetic Analysis Package , 2007 .

[68]  Wei Zheng,et al.  APOBEC3 deletion polymorphism is associated with breast cancer risk among women of European ancestry. , 2013, Carcinogenesis.

[69]  S. Scherer,et al.  Identification of germline genomic copy number variation in familial pancreatic cancer , 2012, Human Genetics.

[70]  M. Hurles,et al.  Copy number variation in human health, disease, and evolution. , 2009, Annual review of genomics and human genetics.

[71]  Ituro Inoue,et al.  Germline copy number variations in BRCA1‐associated ovarian cancer patients , 2011, Genes, chromosomes & cancer.

[72]  A. Ashworth,et al.  Genomic profiling of mitochondrion-rich breast carcinoma: chromosomal changes may be relevant for mitochondria accumulation and tumour biology , 2012, Breast Cancer Research and Treatment.

[73]  Jing Li,et al.  Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome , 1997, Nature Genetics.

[74]  G. Giles,et al.  Increased genomic burden of germline copy number variants is associated with early onset breast cancer: Australian breast cancer family registry , 2017, Breast Cancer Research.

[75]  A. Russo,et al.  Germline copy number variation in the YTHDC2 gene: does it have a role in finding a novel potential molecular target involved in pancreatic adenocarcinoma susceptibility? , 2014, Expert opinion on therapeutic targets.

[76]  J. Foekens,et al.  The 29.5 kb APOBEC3B Deletion Polymorphism Is Not Associated with Clinical Outcome of Breast Cancer , 2016, PloS one.

[77]  Felipe Fidalgo,et al.  Role of rare germline copy number variation in melanoma-prone patients. , 2016, Future oncology.

[78]  J. Mezey,et al.  Glutathione S-transferase copy number variation alters lung gene expression , 2011, European Respiratory Journal.

[79]  Kees Jalink,et al.  Lysophosphatidate-induced cell proliferation: Identification and dissection of signaling pathways mediated by G proteins , 1989, Cell.

[80]  Sambasivarao Damaraju,et al.  Potential novel candidate polymorphisms identified in genome-wide association study for breast cancer susceptibility , 2011, Human Genetics.

[81]  F. Markowetz,et al.  The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups , 2012, Nature.

[82]  Mauno Vihinen,et al.  Copy Number Variation Analysis in Familial BRCA1/2-Negative Finnish Breast and Ovarian Cancer , 2013, PloS one.

[83]  H. Brunner.  Annual Review of Genomics and Human Genetics , 2001, European Journal of Human Genetics.

[84]  Lars Feuk,et al.  The Database of Genomic Variants: a curated collection of structural variation in the human genome , 2013, Nucleic Acids Res..

[85]  A. V. van Kessel,et al.  Identification of candidate predisposing copy number variants in familial and early‐onset colorectal cancer patients , 2011, International journal of cancer.

[86]  Wei Lu,et al.  A common deletion in the APOBEC3 genes and breast cancer risk. , 2013, Journal of the National Cancer Institute.

[87]  A. Yashin,et al.  The Heritability of Breast Cancer: A Bayesian Correlated Frailty Model Applied to Swedish Twins Data , 2004, Twin Research.

[88]  Gabor T. Marth,et al.  A global reference for human genetic variation , 2015, Nature.

[89]  Alison M Dunning,et al.  From candidate gene studies to GWAS and post-GWAS analyses in breast cancer. , 2015, Current opinion in genetics & development.